Core Laboratories Inc. has filed an amended Form 8-K/A with the Securities and Exchange Commission (SEC) to correct certain financial information previously reported in its original Form 8-K filed on February 4, 2026. The amendment addresses an understatement of estimated income tax expense for the quarter and year ended December 31, 2025, which was found to be $4.2 million. This adjustment is primarily linked to a decrease in deferred tax assets and liabilities, as well as an increase in deferred tax expense, reflecting a timing difference related to insurance proceeds from damages at the company's Aberdeen, U.K. facility. The company has stated that this adjustment does not impact consolidated revenue, operating income, or cash from operations as previously reported. The amended report is intended to ensure accuracy in the financial statements ahead of the upcoming filing of the Annual Report on Form 10-K, expected on or around March 17, 2026. The filing is administrative in nature, correcting prior disclosures without introducing new material information that would significantly affect the company's stock price.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.